# A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke

> **NCT01297413** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stemedica Cell Technologies, Inc.** · enrollment: 38 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Allogeneic adult mesenchymal bone marrow stem cells

## Key facts

- **NCT ID:** NCT01297413
- **Lead sponsor:** Stemedica Cell Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2017-09
- **Final completion:** 2018-11-15
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2018-12-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01297413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01297413, "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01297413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*